Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y2MP
|
||||
Former ID |
DIB000184
|
||||
Drug Name |
E-5110
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Terminated | [1] | ||
Company |
Eisai Co Ltd
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C20H29NO3
|
||||
Canonical SMILES |
C1(=O)/C(=C/c2cc(c(c(C(C)(C)C)c2)O)C(C)(C)C)/CCN1OC
|
||||
CAS Number |
CAS 107746-52-1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cyclooxygenase | Target Info | Modulator | [2] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000953) | ||||
REF 2 | Effect of E-5110, a novel non-steroidal anti-inflammatory drug, on trimethadione metabolism as an indicator of hepatic drug-oxidizing capacity in beagle dog. Xenobiotica. 1994 Mar;24(3):215-20. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.